CN112535237A - Mangosteen fermentation extract, preparation method and application - Google Patents
Mangosteen fermentation extract, preparation method and application Download PDFInfo
- Publication number
- CN112535237A CN112535237A CN202011386907.8A CN202011386907A CN112535237A CN 112535237 A CN112535237 A CN 112535237A CN 202011386907 A CN202011386907 A CN 202011386907A CN 112535237 A CN112535237 A CN 112535237A
- Authority
- CN
- China
- Prior art keywords
- mangosteen
- extract
- homogenate
- fermentation
- shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000006053 Garcinia mangostana Species 0.000 title claims abstract description 99
- 235000017048 Garcinia mangostana Nutrition 0.000 title claims abstract description 99
- 239000000284 extract Substances 0.000 title claims abstract description 60
- 238000000855 fermentation Methods 0.000 title claims abstract description 20
- 230000004151 fermentation Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- QTDMGAWIBXJNRR-UHFFFAOYSA-N Mangostin Natural products CC(=CCc1c(O)cc2Oc3cc(C)c(O)c(CC=C(C)C)c3C(=O)c2c1O)C QTDMGAWIBXJNRR-UHFFFAOYSA-N 0.000 claims abstract description 30
- GNRIZKKCNOBBMO-UHFFFAOYSA-N alpha-mangostin Chemical compound OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3OC2=C1 GNRIZKKCNOBBMO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000007788 liquid Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 239000003674 animal food additive Substances 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000001580 bacterial effect Effects 0.000 claims abstract description 9
- 238000005520 cutting process Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 7
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 3
- 239000001963 growth medium Substances 0.000 claims description 15
- 239000002893 slag Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 12
- 230000000813 microbial effect Effects 0.000 claims description 12
- 241000287828 Gallus gallus Species 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 239000002131 composite material Substances 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 6
- 238000009630 liquid culture Methods 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 claims description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229940099596 manganese sulfate Drugs 0.000 claims description 4
- 235000007079 manganese sulphate Nutrition 0.000 claims description 4
- 239000011702 manganese sulphate Substances 0.000 claims description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 238000010008 shearing Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 239000006041 probiotic Substances 0.000 claims description 3
- 235000018291 probiotics Nutrition 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 238000009395 breeding Methods 0.000 claims description 2
- 230000001488 breeding effect Effects 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 230000000529 probiotic effect Effects 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000009374 poultry farming Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 12
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 3
- 238000010298 pulverizing process Methods 0.000 abstract 1
- ZVFQDLCERPGZMO-UHFFFAOYSA-N alpha-mangostin Natural products OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3CC2=C1 ZVFQDLCERPGZMO-UHFFFAOYSA-N 0.000 description 21
- 239000003242 anti bacterial agent Substances 0.000 description 20
- 229940088710 antibiotic agent Drugs 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 241000222122 Candida albicans Species 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 11
- 229940095731 candida albicans Drugs 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 10
- 241000191967 Staphylococcus aureus Species 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 229960003085 meticillin Drugs 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 238000001238 wet grinding Methods 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- -1 xanthone compound Chemical class 0.000 description 3
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone powder Natural products C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000593508 Garcinia Species 0.000 description 2
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 2
- 229960002064 kanamycin sulfate Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960001572 vancomycin hydrochloride Drugs 0.000 description 2
- LCTORFDMHNKUSG-XTTLPDOESA-N vancomycin monohydrochloride Chemical compound Cl.O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 LCTORFDMHNKUSG-XTTLPDOESA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Animal Husbandry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Sustainable Development (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a mangosteen extract with high mangostin content, and a preparation method and application thereof. The preparation method of the mangosteen extract with high mangostin content specifically comprises the following steps: pulverizing a mangosteen shell raw material to obtain mangosteen shell powder; mixing the mangosteen shell powder with water, emulsifying, stirring and cutting for multiple times to obtain mangosteen shell homogenate; uniformly mixing the mangosteen shell homogenate with the activated bacterial liquid for fermentation; performing solid-liquid separation after fermentation to obtain mangosteen shell fermentation product; mixing and extracting the mangosteen shell fermentation product with an alcohol-water extracting agent to obtain a mangosteen shell fermentation alcohol extract; concentrating and drying to obtain mangosteen extract with high mangostin content, which is suitable for being used as feed additive for resisting bacteria and promoting growth.
Description
Technical Field
The invention belongs to the field of natural plant extraction, and relates to a preparation method and application of a mangosteen extract.
Background
Antibiotics refer to a class of substances produced by bacteria, fungi, or other microorganisms that have anti-pathogenic or other activity. Due to the abuse of antibiotics in recent years, pathogenic bacteria develop resistance to antibiotics and antibiotics may remain in animal products. With the increasing emphasis on food safety in recent years, the focus is on finding antibiotics for feeding, and solving the problem of animal-derived food safety. The Chinese herbal medicine additive has unique advantages in promoting animal growth and improving immunity, so that research strength of the Chinese herbal medicine as the feed additive is further increased, and the Chinese herbal medicine anti-cancer additive has a wide application prospect in development and application of a reliable curative effect, small toxic and side effects, convenience in application and low cost.
Mangosteen, originally named mangosteen, is a plant of the genus garcinia of the family garciniaceae, and is mainly distributed in southeast Asia countries such as Thailand, Vietnam, Malaysia, Indonesia, Philippines, and the like. The pericarp of the mangosteen is always used as a traditional medicine in southeast Asia countries for treating diseases such as abdominal pain, diarrhea, dysentery, cholera, infected wounds, suppuration, chronic ulcer and the like, and modern scientific researches find that the pericarp of the mangosteen contains various active ingredients including bispyridone, phenolic acid, polysaccharide, pigment and the like, has pharmacological activities in various aspects such as anti-inflammation, antibiosis, malaria prevention, blood fat reduction, antioxidation, HIV resistance, immunoregulation and the like, is a plant resource with multiple effects, and is worthy of deep research and wide popularization. The xanthone compound is considered as a main active ingredient of mangosteen shell with drug effect and health care value, and the main active ingredient of the xanthone compound is mangostin (mangostin), so that the xanthone compound has good effect in the field of antibiosis and antiphlogosis.
At present, there are many reports related to the production process of mangosteen extract, such as chinese patent publication No. CN201310340403.6, a mangosteen extract and its application, CN111170981A, a garcinia extract extracted from mangosteen, its preparation method and its application, CN201710310190.0, a mangosteen extract for treating gout, and its preparation method. The patent methods adopt conventional extraction processes such as leaching, thermal reflux, ultrasonic and the like, and are difficult to completely break firm cell walls of the mangosteen shell powder raw material, so that effective components in plants cannot be well extracted and utilized, not only is resource waste caused, but also the prospect of the mangosteen extract as an antibacterial raw material is influenced. In fact, many polyphenols and polysaccharides exist in the mangosteen besides antibacterial substances such as mangostin, and substances with low application value in mangosteen shells are further converted into substances with high application value by a fermentation method, so that the application value of the mangosteen extract is improved. Based on the background, the invention further researches the physical and biotransformation extraction method of the mangosteen, so as to further obtain the process technology of the mangosteen extract which is more comprehensive and more suitable for being used as a feed additive for replacing antibiotics than the common extract, and particularly obtain the application method of the extract.
Disclosure of Invention
The invention aims to provide a physical-microbial composite wall-breaking extraction preparation method which is easy to operate and can efficiently produce mangosteen extract rich in mangosteen, beneficial components such as mangosteen, polyphenol, polysaccharide and the like in mangosteen, and enzymes, probiotics, polypeptides and other nutrient substances formed by fermentation are extracted at one time, and the extract is used in the field of feed additives, and is applied to the fields of antibacterial function extract, substitute antibiotics and growth promotion as feed additives.
The preparation process method related by the invention comprises the following steps: through a mechanical wet grinding mode, the mangosteen shells are gradually ground into a fine particle state in water as much as possible, then grinding liquids (homogeneous liquids) are combined, fermentation wall breaking and conversion are further carried out by a microbial fermentation method, and finally, conventional alcohol-water solution is used for extraction, and conventional spray drying is used for drying, so that the mangosteen extract with unexpected effect on antibacterial effect is obtained.
In order to achieve the purpose, the invention adopts the following process steps:
1) drying or baking fresh mangosteen, crushing the raw materials, and sieving the crushed raw materials with a 20-mesh sieve to obtain a mangosteen shell crushed material;
2) mixing the pulverized mangosteen shell with water, emulsifying, stirring and cutting in a homogenizer to obtain mangosteen shell homogenate, sterilizing and cooling; the preparation method of the mangosteen shell homogenate comprises the following steps: mixing the mangosteen shell crushed material with water according to the mass ratio of 1 (5-7), homogenizing and shearing for 0.4-1 h to obtain first fine crushed pulp and first fine crushed slag precipitated at the bottom of the water, and filtering and separating; adding water into the first fine crushed slag to carry out secondary homogenizing shearing to obtain second fine crushed pulp and second fine crushed slag deposited at the bottom of the water, and filtering and separating; homogenizing and separating for 5 times, and mixing all fine pulp to obtain mangosteen homogenate;
3) adding activated composite microbial strain culture solution into the homogenate, and performing fermentation culture at 32-36 deg.C and 160 r/min; the culture medium formula for activating the strains is 10.0g/L peptone, 10.0g/L yeast extract, 2.0g/L diammonium hydrogen citrate, 0.6 g/L magnesium sulfate, 2.0g/L dipotassium hydrogen phosphate, 0.3 g/L manganese sulfate, 1.0mL Tween-80 and the pH value is 6.2-6.6. The activated composite microbial strain is prepared by culturing lactobacillus plantarum powder and saccharomyces cerevisiae powder in a ratio of 1:3 in a liquid culture medium until the number of bacterial colonies reaches 108Liquid seed culture in CFU/ml. The inoculation mass of the composite microbial strain culture solution is 15-20% of the mass of mangosteen homogenate, and the fermentation time is 72 h;
4) filtering the fermented substance; adding 60-80% ethanol into the filter residue according to the mass ratio of 1:5-1:7, performing ultrasonic extraction for 30min, filtering, and repeating the above operation once; mixing the three filtrates, vacuum concentrating under reduced pressure to more than 10 Baume degree, stirring, homogenizing, adding appropriate adjuvants, and spray drying to obtain powdery mangosteen extract rich in mangostin, polypeptide, polyphenol, and probiotic.
The invention has the following beneficial effects:
1. the batch high shear mode of the homogenizer can break plant cell walls. The microbial fermentation further destroys the cell tissue structure of the plant by utilizing the physiological process of the microorganism, decomposes the plant tissue into small molecular substances, reduces the extraction mass transfer resistance, fully releases active ingredients, and has the characteristics of stable extraction, high purity, low energy consumption, high efficiency and the like. The physical rolling and microbial fermentation modes are combined, plant cell walls can be efficiently crushed, active ingredients are fully released, and meanwhile, carbohydrate in the mangosteen shells is used as a carbon source, so that carbohydrate and water-soluble pigment impurities are reduced, and small molecular substances which are easy to absorb by intestinal tracts and improve intestinal tract steady state are generated.
2. The invention has simple process condition, short production period and low cost, and the used raw materials are pure natural components, are safe, have no pollution, and are cheap and easy to obtain. Compared with the mangosteen extract prepared by pure water extraction and alcohol extraction, the mangosteen extract prepared by the method has the advantages that the mangosteen extract has obviously improved mangostin extraction rate, has good antibacterial rate on methicillin-resistant staphylococcus aureus and candida albicans, has obviously enhanced inhibition effect on gram negative bacteria such as escherichia coli and the like, and has wide application prospect in the field of replacing antibiotics and preservatives.
Detailed Description
The technical solutions of the present invention are further described below by specific examples, but the present invention is not limited thereto. The invention is not limited to the above embodiments, but may be modified and replaced by other embodiments.
Example 1
1) Drying 3.0 kg of fresh mangosteen, crushing the raw materials, and sieving the crushed raw materials with a 20-mesh sieve to obtain 1.17 kg of crushed mangosteen powder;
2) mixing the mangosteen shell crushed material with 6kg of water, putting the mixture into a high-speed refiner, carrying out wet grinding and stirring for 25min, and then carrying out centrifugal settling separation to obtain first fine crushed pulp and 1.40kg of first fine crushed slag (small loss is not counted) precipitated at the bottom of water; keeping the fine crushed pulp for standby, adding 6kg of water into the first fine crushed slag, carrying out second wet grinding, stirring and cutting to obtain 0.81kg of second fine crushed pulp and second settled fine crushed slag; then continuously carrying out wet grinding and stirring cutting for 3 times in a mode of slag-liquid ratio of 1:5, and finally obtaining fifth fine crushed pulp and a very small amount of fifth fine crushed slag. The five fine crushed pulps are combined to obtain 29kg of mangosteen homogenate.
3) Adding 4.35kg of activated composite microbial strain culture solution into the mangosteen homogenate, and performing fermentation culture at 32 ℃ and 160r/min for 72 h; the culture medium formula for activating the strains is 10.0g/L peptone, 10.0g/L yeast extract, 2.0g/L diammonium hydrogen citrate, 0.6 g/L magnesium sulfate, 2.0g/L dipotassium hydrogen phosphate, 0.3 g/L manganese sulfate, 1.0mL Tween-80 and the pH value is 6.2-6.6. The activated composite microbial strain is prepared by culturing lactobacillus plantarum powder and saccharomyces cerevisiae powder in a ratio of 1:3 in a liquid culture medium until the number of bacterial colonies reaches 108Liquid seed culture in CFU/ml.
4) Filtering the fermented substance to obtain 0.62 kg of filter residue; adding 0.6kg of 60% ethanol into the filter residue according to the mass ratio of 1:5, performing ultrasonic extraction for 30min, filtering to obtain 0.27kg of filter residue, and repeating the above operation once; mixing the three filtrates, vacuum concentrating under reduced pressure to 18 kg, adding dextrin 2kg, stirring, homogenizing, and spray drying to obtain 2.9 kg of mangosteen extract (with adhesive loss in spray drying stage);
and (3) taking an alpha-mangostin reference substance (with the content of 99.5%) as a standard working curve, and measuring the content of the alpha-mangostin in the obtained mangosteen extract dry powder by adopting a high performance liquid chromatography to obtain the content of the alpha-mangostin in the mangosteen extract of 5.46%.
Example 2
1) Drying 2.0kg of fresh mangosteen, crushing, and sieving with a 20-mesh sieve to obtain 768g of mangosteen shell crushed material;
2) mixing the mangosteen shell crushed material with 4kg of water, homogenizing at high speed, stirring and cutting for 30min, and performing centrifugal sedimentation to obtain 826g of first fine crushed pulp and first fine crushed slag at the bottom of precipitation; 4.5kg of water is added into the first fine crushed slag to carry out secondary high-speed homogenizing stirring and cutting to obtain second fine crushed pulp and 321g of second fine crushed slag deposited at the bottom of the water; continuously carrying out stirring separation circulation for 3 times to obtain fifth fine crushed pulp (the fifth fine crushed slag is less than 20 g); mixing the fine crushed pulp to obtain 19.3kg of mangosteen homogenate, and discarding the final fine crushed slag;
3) adding activated complex microorganism strain into the combined fine crushing paddle3.86kg of culture solution, and carrying out fermentation culture for 72h at the temperature of 32 ℃ and the rotating speed of 160 r/min; the culture medium formula for activating the strains is 10.0g/L peptone, 10.0g/L yeast extract, 2.0g/L diammonium hydrogen citrate, 0.6 g/L magnesium sulfate, 2.0g/L dipotassium hydrogen phosphate, 0.3 g/L manganese sulfate, 1.0mL Tween-80 and the pH value is 6.2-6.6. The activated composite microbial strain is prepared by culturing lactobacillus plantarum powder and saccharomyces cerevisiae powder in a ratio of 1:3 in a liquid culture medium until the number of bacterial colonies reaches 108Liquid seed culture in CFU/ml.
4) Filtering the fermented substance to obtain about 0.41kg of filter residue; adding 80% ethanol 0.7kg into the residue at a solid-to-liquid ratio of 1:7, ultrasonic treating for 30min, filtering, and repeating the above steps; mixing the three filtrates, vacuum concentrating under reduced pressure to 8kg, adding dextrin 1kg, stirring, homogenizing, and spray drying to obtain 1.4kg of mangosteen extract;
and (3) taking an alpha-mangostin reference substance (with the content of 99.5%) as a standard working curve, and measuring the content of the alpha-mangostin in the obtained mangosteen extract dry powder by adopting a high performance liquid chromatography to obtain the content of the alpha-mangostin in the mangosteen extract of 5.94%.
Example 3
The antibacterial activity of the mangosteen extract of example 1 against methicillin-resistant staphylococcus aureus, candida albicans, escherichia coli was determined: in this example, the Minimal Inhibitory Concentration (MIC) of methicillin-resistant Staphylococcus aureus, Candida albicans, and Escherichia coli activity of the sample was determined by Resazurin color development.
1) Preparing a methicillin-resistant staphylococcus aureus, candida albicans and escherichia coli liquid: respectively adopting fungus culture medium and bacteria culture medium, preparing liquid culture medium, culturing methicillin-resistant Staphylococcus aureus, Candida albicans and Escherichia coli, preparing bacteria liquid, and preparing bacterial suspension with concentration of 107-108CFU/ml；
2) Preparation of a sample solution: weighing the mangosteen extract obtained in example 1, and preparing a mangosteen extract sample solution of 2.5mg/ml (calculated by the content of alpha-mangostin) by using a dimethyl sulfoxide (DMSO) solution;
3) preparation of a resazurin developing solution: weighing 2.4mg of resazurin color developing agent, and dissolving with 24ml of deionized water;
4) preparing a resazurin-bacterium liquid mixed solution: mixing the color development liquid and the bacterial liquid according to the proportion of 3: 2;
5) 96-well plate gradient dilution assay: taking 20ul of sample solution respectively, repeating 2 holes in parallel in a first row of 96 holes, adding 180ul of the resazurin-bacterial liquid mixed solution in the first row, and adding 100ul of the resazurin-bacterial liquid mixed solution in other rows; after the first row is mixed by re-suction, 100uL of the solution is taken out and transferred to the corresponding plate hole of the second row, and the solution is multiplied and diluted to the 8 th row by the same method. Finally, the well plate added with the sample is placed into a constant temperature incubator and cultured for 8-10h at 37 ℃. The bacteria liquid turns red into no bacteriostatic activity, blue is bacteriostatic activity, and the lowest dilution concentration of the bacteria liquid maintaining blue is considered as the lowest bacteriostatic concentration of the compound to be detected. The minimum inhibitory concentration of the mangosteen extract to methicillin-resistant staphylococcus aureus and candida albicans is 18ug/ml (calculated by the content of alpha-mangostin) and the minimum inhibitory concentration of the mangosteen extract to escherichia coli is 135ug/ml (calculated by the content of alpha-mangostin) by taking vancomycin hydrochloride and kanamycin sulfate as positive controls and taking a dimethyl sulfoxide (DMSO) solution as a blank control.
Example 4
A prepared mangosteen extract with the content of alpha-mangostin of 10.2% (a control sample obtained by ultrasonic extraction twice by using 60% ethanol water solution as an extracting agent, 30min each time, concentration and spray drying) is subjected to the same dilution control test of a 96-well plate as in example 3 to compare the difference of antibacterial performance of a homogeneous fermentation extract and a common extract.
And (3) determining the Minimum Inhibitory Concentration (MIC) of the activity of methicillin-resistant staphylococcus aureus, candida albicans and escherichia coli of the sample by adopting a resazurin color development method.
1) Preparing a methicillin-resistant staphylococcus aureus, candida albicans and escherichia coli liquid: respectively adopting fungus culture medium and bacteria culture medium, preparing liquid culture medium, culturing methicillin-resistant Staphylococcus aureus, Candida albicans and Escherichia coli, preparing bacteria liquid, and preparing bacterial suspension with concentration of 107-108CFU/ml；
2) Preparation of a sample solution: weighing a conventional mangosteen extract with the content of 10.2 percent of alpha-mangostin, and preparing a mangosteen extract sample solution with the content of 2.5mg/ml (calculated by the content of the alpha-mangostin) by using a dimethyl sulfoxide (DMSO) solution;
3) preparation of a resazurin developing solution: weighing 2.4mg of resazurin color developing agent, and dissolving with 24ml of deionized water;
4) preparing a resazurin-bacterium liquid mixed solution: mixing the color development liquid and the bacterial liquid according to the proportion of 3: 2;
5) 96-well plate gradient dilution assay: taking 20ul of sample solution respectively, repeating 2 holes in parallel in a first row of 96 holes, adding 180ul of the resazurin-bacterial liquid mixed solution in the first row, and adding 100ul of the resazurin-bacterial liquid mixed solution in other rows; after the first row is re-pipetted and mixed, 100. mu.L of the solution is transferred to the corresponding well in the second row and is multiply diluted to row 8 in the same way. Finally, the well plate added with the sample is placed into a constant temperature incubator and cultured for 8-10h at 37 ℃. The bacteria liquid turns red into no bacteriostatic activity, blue is bacteriostatic activity, and the lowest dilution concentration of the bacteria liquid maintaining blue is considered as the lowest bacteriostatic concentration of the compound to be detected. By taking vancomycin hydrochloride and kanamycin sulfate as positive controls and taking dimethyl sulfoxide (DMSO) solution as a blank control, the minimum inhibitory concentration of the mangosteen extract to methicillin-resistant staphylococcus aureus and candida albicans is 27 mu g/ml (calculated by the content of alpha-mangostin), and the minimum inhibitory concentration to escherichia coli is 635ug/ml (calculated by the content of alpha-mangostin).
Therefore, under the condition of comparing solutions with the same content of alpha-mangostin, the mangosteen extract obtained by adopting the homogenization-fermentation-extraction-drying process has obviously improved inhibition effect on gram-positive bacteria and candida albicans and obviously enhanced inhibition effect on gram-negative bacteria (escherichia coli) compared with the mangosteen extract obtained by the conventional extraction method. Therefore, the mangosteen extract obtained by the invention has bacteriostasis capability superior to that of common mangosteen extracts, and has potential application prospect in the field of replacing antibiotics and antiseptics.
Example 5
The mangosteen extract obtained in example 1 was mixed with corn starch to form a premix having an α -mangostin content of 2.0% and used as a feed additive instead of antibiotics. The premix is added into daily ration of broiler chickens according to the adding proportion of 1 kilogram per ton, and the mixture is pressed into feed particles. The growth promotion experiment is carried out on 15-day-old chicks consisting of 200 experimental groups to 200 control groups for 15 days, and antibiotics and other growth promotion feed additives are not used in the experimental group and the control group in the experimental process.
The experimental results show that: the number of dead chicks in the experimental group is 2, and the weight of the chicks is increased by 2.15kg in 15 balances; the number of dead chicks in the control group is 32, and the average weight is increased by 1.78 kg.
Example 6
The mangosteen extract obtained in example 1 and corn starch are mixed into a premix with the alpha-mangostin content of 2.0%, and the premix is used as a daily ration additive for broiler chickens to replace antibiotics. The premix is added into daily ration of broiler chickens according to the adding proportion of 1.5 kg per ton, and the mixture is pressed into feed particles. The growth promotion experiment is carried out on 15-day-old chicks consisting of 200 experimental groups to 200 control groups for 15 days, and antibiotics and other growth promotion feed additives are not used in the experimental group and the control group in the experimental process.
The experimental results show that: the number of dead chicks in the experimental group is 0, and the weight of the chicks is increased by 2.20kg in 15 balances; the number of dead chicks in the control group is 28, and the average weight is increased by 1.90 kg.
Example 7
The mangosteen extract obtained in example 1 and corn starch are mixed into a premix with the alpha-mangostin content of 2.0%, and the premix is used as a daily ration additive for broiler chickens to replace antibiotics. The premix is added into daily ration of broiler chickens according to the adding proportion of 2.0kg per ton, and the mixture is pressed into feed particles. The growth promotion experiment is carried out on 15-day-old chicks consisting of 200 experimental groups to 200 control groups for 15 days, and antibiotics and other growth promotion feed additives are not used in the experimental group and the control group in the experimental process.
The experimental results show that: the number of dead chicks in the experimental group is 0, and the weight of the chicks is increased by 2.40kg in 15 balances; the number of dead chicks in the control group is 29, and the average weight is increased by 1.88 kg.
Example 8
The mangosteen extract obtained in example 1 and corn starch are mixed into a premix with the alpha-mangostin content of 2.0%, and the premix is used as a daily ration additive for broiler chickens to replace antibiotics. The premix is added into daily ration of broiler chickens according to the adding proportion of 2.0kg per ton, and the mixture is pressed into feed particles. The growth promotion experiment is carried out on 15-day-old chicks consisting of 200 experimental groups to 200 control groups for 15 days, and antibiotics and other growth promotion feed additives are not used in the experimental group and the control group in the experimental process.
The experimental results show that: the number of dead chicks in the experimental group is 0, and the weight of the chicks is increased by 2.20kg in 15 balances; the number of dead chicks in the control group is 22, and the average weight is increased by 1.80 kg.
Example 9
Commercially available mangosteen extract (17% of alpha-mangostin determined by high performance liquid chromatography) and corn starch are mixed into premix with 2.0% of alpha-mangostin, and the premix is used as broiler ration additive for replacing antibiotics. The premix is added into daily ration of broiler chickens according to the adding proportion of 2.0kg per ton, and the mixture is pressed into feed particles. The growth promotion experiment is carried out on 15-day-old chicks consisting of 200 experimental groups to 200 control groups for 15 days, and antibiotics and other growth promotion feed additives are not used in the experimental group and the control group in the experimental process.
The experimental results show that: the number of dead chicks in the experimental group is 6, and the weight of the chicks is increased by 2.08kg in 15 balances; the number of dead chicks in the control group is 25, and the average weight is increased by 1.77 kg.
Experiments show that the mangosteen extract prepared by the invention has a certain antibiotic effect on broiler chickens, has a growth promoting function, and can be used as a natural extract feed additive for replacing antibiotics to be used for poultry breeding. Although aquatic and mammalian studies have not been conducted, it is anticipated that the mangosteen extract prepared by the present invention may also have antibacterial and growth promoting effects in other animal breeding fields.
Claims (6)
1. A mangosteen fermentation extract is characterized by adopting the following preparation steps:
1) drying or baking fresh mangosteen, crushing the raw materials, and sieving the crushed raw materials with a 20-mesh sieve to obtain a mangosteen shell crushed material;
2) mixing the pulverized mangosteen shell with water, emulsifying, stirring and cutting in a homogenizer to obtain mangosteen shell homogenate, sterilizing and cooling; the preparation method of the mangosteen shell homogenate comprises the following steps: mixing the mangosteen shell crushed material with water according to the mass ratio of 1 (5-7), homogenizing and shearing for 0.4-1 h to obtain first fine crushed pulp and first fine crushed slag precipitated at the bottom of the water, and filtering and separating; adding water into the first fine crushed slag to carry out secondary homogenizing shearing to obtain second fine crushed pulp and second fine crushed slag deposited at the bottom of the water, and filtering and separating; homogenizing and separating for 5 times, and mixing all fine pulp to obtain mangosteen homogenate;
3) adding activated composite microbial strain culture solution into the homogenate, and performing fermentation culture at 32-36 deg.C and 160 r/min; the formula of the culture medium for activating the strains is 10.0g/L peptone, 10.0g/L yeast extract, 2.0g/L diammonium hydrogen citrate, 0.6 g/L magnesium sulfate, 2.0g/L dipotassium hydrogen phosphate, 0.3 g/L manganese sulfate, 1.0mL of Tween-80 and the pH value of the culture medium is 6.2-6.6;
the activated composite microbial strain is prepared by culturing lactobacillus plantarum powder and saccharomyces cerevisiae powder in a ratio of 1:3 in a liquid culture medium until the number of bacterial colonies reaches 108Liquid spawn of CFU/ml; the inoculation mass of the composite microbial strain culture solution is 15-20% of the mass of mangosteen homogenate, and the fermentation time is 72 h;
4) filtering the fermented substance; adding 60-80% ethanol into the filter residue according to the mass ratio of 1:5-1:7, performing ultrasonic extraction for 30min, filtering, and repeating the above operation once; mixing the three filtrates, vacuum concentrating under reduced pressure to more than 10 Baume degree, stirring, homogenizing, adding appropriate adjuvants, and spray drying to obtain powdery mangosteen extract rich in mangostin, polypeptide, polyphenol, and probiotic.
2. Use of the mangosteen extract of claim 1 in animal feed stocks.
3. Use of the mangosteen extract according to claim 1 in a poultry farming feed.
4. Use of the mangosteen extract of claim 1 in broiler breeding feed.
5. Use of the mangosteen extract of claim 1 in the replacement of antibiotic feed additives and feed additive raw materials.
6. Use of the mangosteen extract of claim 1 in growth-promoting feed additives and feed additive raw materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011386907.8A CN112535237A (en) | 2020-12-02 | 2020-12-02 | Mangosteen fermentation extract, preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011386907.8A CN112535237A (en) | 2020-12-02 | 2020-12-02 | Mangosteen fermentation extract, preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112535237A true CN112535237A (en) | 2021-03-23 |
Family
ID=75016995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011386907.8A Pending CN112535237A (en) | 2020-12-02 | 2020-12-02 | Mangosteen fermentation extract, preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112535237A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115590846A (en) * | 2022-10-27 | 2023-01-13 | 中国农业科学院兰州畜牧与兽药研究所（Cn） | Application of alpha-mangostin in preparation of preparation for inhibiting formation of escherichia coli biofilm |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396101A (en) * | 2008-09-17 | 2009-04-01 | 丁予章 | Production technique of mangosteen extract |
| CN106187977A (en) * | 2016-07-06 | 2016-12-07 | 丘利锦 | A kind of method extracting Garcinia mangostana shell procyanidins |
| CN107595922A (en) * | 2017-10-30 | 2018-01-19 | 中国科学院昆明植物研究所 | The preparation method of main component and its application in pharmacy in a kind of mangosteen shell |
| CN108850630A (en) * | 2017-05-15 | 2018-11-23 | 中国热带农业科学院海口实验站 | A kind of mangosteen ferment chicken feed |
| CN111642622A (en) * | 2019-12-30 | 2020-09-11 | 广州立达尔生物科技股份有限公司 | Preparation and application of fermentation composite bacteria and myrtle fermentation extract |
-
2020
- 2020-12-02 CN CN202011386907.8A patent/CN112535237A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396101A (en) * | 2008-09-17 | 2009-04-01 | 丁予章 | Production technique of mangosteen extract |
| CN106187977A (en) * | 2016-07-06 | 2016-12-07 | 丘利锦 | A kind of method extracting Garcinia mangostana shell procyanidins |
| CN108850630A (en) * | 2017-05-15 | 2018-11-23 | 中国热带农业科学院海口实验站 | A kind of mangosteen ferment chicken feed |
| CN107595922A (en) * | 2017-10-30 | 2018-01-19 | 中国科学院昆明植物研究所 | The preparation method of main component and its application in pharmacy in a kind of mangosteen shell |
| CN111642622A (en) * | 2019-12-30 | 2020-09-11 | 广州立达尔生物科技股份有限公司 | Preparation and application of fermentation composite bacteria and myrtle fermentation extract |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115590846A (en) * | 2022-10-27 | 2023-01-13 | 中国农业科学院兰州畜牧与兽药研究所（Cn） | Application of alpha-mangostin in preparation of preparation for inhibiting formation of escherichia coli biofilm |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106993807A (en) | A kind of preparation method of ginger ferment | |
| CN111642622A (en) | Preparation and application of fermentation composite bacteria and myrtle fermentation extract | |
| CN103060228A (en) | Lactobacillus plantarum and micro-ecological preparation for silage | |
| CN114107403B (en) | Method for co-producing ellagic acid and biological feed by fermenting pericarpium Granati with microbial community | |
| CN112535237A (en) | Mangosteen fermentation extract, preparation method and application | |
| CN113100345A (en) | Pig feed additive for improving immunity and preparation method of pig feed | |
| CN110050941B (en) | Aspergillus flavus growth inhibition and aflatoxin B degradation1Method (2) | |
| CN116355816A (en) | Microorganism of fermented samara oil seed and blood lipid reducing composition thereof | |
| CN114698767B (en) | Biological agent for removing mycotoxin in feed as well as preparation method and application of biological agent | |
| CN115708841A (en) | Compound preparation for degrading ochratoxin as well as preparation method and application thereof | |
| CN102212480A (en) | Method for producing yeast extract by utilizing tetracycline decoction dregs | |
| KR101252134B1 (en) | Feed additives for promoting growth of cattle and process for the preparation of feed for breeding cattle using the same | |
| CN112316009B (en) | Application of cerasus humilis extract in preparation of antibacterial product | |
| CN114574384A (en) | Biopesticide extracted from microbial plants and application thereof | |
| US20220287342A1 (en) | A strain of yarrowia lipolytica and its use in preparing a low-sugar and low-fat nutritional powder of desiccated coconut | |
| CN106478163A (en) | A kind of soy protein wastewater sludge organism fertilizer and preparation method thereof | |
| CN111748493A (en) | Preparation method and application of compound microbial preparation | |
| CN107779404B (en) | Ralstonia alba and culture method and application thereof | |
| CN111345419A (en) | Compound fermentation type shark cartilage powder health drink | |
| RU2779648C2 (en) | Method for obtaining a biologically active feed additive for farm animals and poultry | |
| CN115353981B (en) | Liquid fermentation culture method of trephine hirsutum and active metabolite | |
| CN114181858B (en) | Functional feed additive for preventing and treating necrotic enteritis of birds and preparation method thereof | |
| CN112725222B (en) | Bacillus subtilis Q3 for producing complex enzyme, culture method and application | |
| AU2020102037A4 (en) | A method of efficiently increasing the alpha-glucosidase inhibitor content in fresh mulberry leaves by the solid-state fermentation | |
| CN111685224B (en) | Antibiotic-free feed additive containing antibacterial peptide and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210323 |
|
| WD01 | Invention patent application deemed withdrawn after publication |